Cell Reports (Feb 2016)

Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals

  • Fengqin Fang,
  • Mingcan Yu,
  • Mary M. Cavanagh,
  • Jessica Hutter Saunders,
  • Qian Qi,
  • Zhongde Ye,
  • Sabine Le Saux,
  • William Sultan,
  • Emerson Turgano,
  • Cornelia L. Dekker,
  • Lu Tian,
  • Cornelia M. Weyand,
  • Jörg J. Goronzy

Journal volume & issue
Vol. 14, no. 5
pp. 1218 – 1231

Abstract

Read online

Summary: In an immune response, CD4+ T cells expand into effector T cells and then contract to survive as long-lived memory cells. To identify age-associated defects in memory cell formation, we profiled activated CD4+ T cells and found an increased induction of the ATPase CD39 with age. CD39+ CD4+ T cells resembled effector T cells with signs of metabolic stress and high susceptibility to undergo apoptosis. Pharmacological inhibition of ATPase activity dampened effector cell differentiation and improved survival, suggesting that CD39 activity influences T cell fate. Individuals carrying a low-expressing CD39 variant responded better to vaccination with an increase in vaccine-specific memory T cells. Increased inducibility of CD39 after activation may contribute to the impaired vaccine response with age. : Fang et al. report that the ATPase activity of CD39 regulates differentiation and apoptosis of effector T cells. They propose that increased CD39 expression in T cells with age promotes T cell apoptosis in older individuals and contributes to age-dependent impairment in responses to vaccination.